CXCR2 and breast carcinoma: Evidence have shown that CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways [36], while MMP3 contributes to the precision of epithelial cell branching via the processing of ECM components [37].